www.fdanews.com/articles/179549-former-fda-official-strikes-settlement-with-sec-over-insider-trading
![](https://www.fdanews.com/ext/resources/test/Drug-Images4/CourtHouse_Image.gif?t=1481153791&width=430)
Former FDA Official Strikes Settlement with SEC Over Insider-Trading
December 7, 2016
A former FDA official reached an agreement to settle SEC charges for allegedly sharing confidential information on generics approvals with a hedge fund manager.
Gordon Johnston, a former deputy director for the Office of Generic Drugs, will pay $108,000 —the amount he earned from consultant fees — to resolve the allegations that he solicited information from FDA personnel to alert a portfolio manager when enoxaparin ANDAs moved toward approval.
The settlement comes after Johnston pleaded guilty to a related case involving securities fraud in June.